Form 8-K - Current report:
SEC Accession No. 0001193125-22-274491
Filing Date
2022-11-01
Accepted
2022-11-01 07:30:37
Documents
15
Period of Report
2022-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d395813d8k.htm   iXBRL 8-K 61911
2 EX-2.1 d395813dex21.htm EX-2.1 651787
3 EX-99.1 d395813dex991.htm EX-99.1 29191
  Complete submission text file 0001193125-22-274491.txt   1091699

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA jnj-20221031.xsd EX-101.SCH 4710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnj-20221031_def.xml EX-101.DEF 14286
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnj-20221031_lab.xml EX-101.LAB 24009
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnj-20221031_pre.xml EX-101.PRE 15377
9 EXTRACTED XBRL INSTANCE DOCUMENT d395813d8k_htm.xml XML 8426
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 221348504
SIC: 2834 Pharmaceutical Preparations